Company Monitoring Page for Merck

latest headlines for company on cafepharma

Merck's ADC hunt continues with second deal for China biotech Kelun
Endpoints
Tue, 07/26/22 - 05:24 pm
Tags:
Merck, antibody-drug conjugate, solid tumors, China, Kelun Biotech
Seagen, Astellas claim positive results in study key to cancer drug's success
BioPharma Dive
Tue, 07/26/22 - 11:26 am
Tags:
Seagen, Astellas, Padcev, Merck, Keytruda, bladder cancer, clinical trials
Merck’s Keytruda fails head and neck cancer trial
CNBC
Wed, 07/20/22 - 09:44 am
Tags:
Merck, Keytruda, head and neck cancer, clinical trials
Merck to stop Phase 3 trial of Lynparza drug in colorectal cancer for futility
Seeking Alpha
Tue, 07/19/22 - 10:18 am
Tags:
Merck, clinical trials, Lynparza, colorectal cancer
Merck potential purchase of Seagen said unlikely by earnings date - report
Seeking Alpha
Sun, 07/17/22 - 11:05 pm
Tags:
Merck, Seagen, earnings, M&A
Orion raises outlook after Merck deal on developing prostate cancer drug
Reuters
Wed, 07/13/22 - 10:40 am
Tags:
Orion, Merck, prostate cancer, drug development
Merck accelerator welcomes biotech start-ups specializing in AI and machine learning
Biopharma Reporter
Tue, 07/12/22 - 10:38 am
Tags:
Merck, Merck Digital Sciences Studio, accelerators, machine learning, drug discovery, R&D, artificial intelligence
FDA is letting pharmacists prescribe Pfizer's Paxlovid but won't do the same for Merck's Lagevrio
Fierce Pharma
Fri, 07/8/22 - 10:59 am
Tags:
Pfizer, Merck, Paxlovid, Lagevrio, FDA, pharmacists, COVID-19
Report: Merck in Advanced Talks to Acquire Seagen for $40B
BioSpace
Thu, 07/7/22 - 10:43 am
Tags:
Merck, M&A, Seagen, oncology
The trigger for a Seagen buyout
EP Vantage
Thu, 06/30/22 - 10:55 am
Tags:
Merck, Seagen, M&A
Move over Medtech, Pharma Is Embracing AI, Too!
Medical Devices and Diagnostics Industry
Wed, 06/29/22 - 05:29 pm
Tags:
Medtech, Merck, Bayer, machine learning, artificial intelligence
Merck to support Transgene and BioInvent led oncolytic virus clinical trial
Biopharma Reporter
Tue, 06/28/22 - 05:49 pm
Tags:
Merck, Keytruda, clinical trials, Transgene, Bioinvent, solid tumors
A Merck partner is sucked into the financial quagmire as key lender calls in a note
Endpoints
Mon, 06/27/22 - 06:40 pm
Tags:
Merck, 4D Pharma
Acquisition in the air? Merck and Seagen to meet this week: WSJ
Fierce Pharma
Fri, 06/24/22 - 12:22 pm
Tags:
Merck, Seagen, M&A
US: Merck doubles production capacity of ADC components
Biopharma Reporter
Thu, 06/23/22 - 07:54 pm
Tags:
Merck, antibody-drug conjugate, drug manufacturing
Merck outflanks Pfizer's 20-valent shot with pneumococcal vaccine approval for kids
Endpoints
Wed, 06/22/22 - 10:57 am
Tags:
Merck, FDA, vaccines, pneumococcal disease, Vaxneuvance, Pfizer
SVB Leerink's Pro-forma Analysis Of Speculated Merck/Seagen Deal
Yahoo/Benzinga
Wed, 06/22/22 - 10:50 am
Tags:
Merck, Seagen, M&A
Illumina Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome
BioSpace
Wed, 06/22/22 - 10:26 am
Tags:
Medtech, diagnostics, Illumina, Myriad Genetics, TruSight Oncology 500, cancer, Merck
BMS, Pfizer and Merck face steep patent cliffs but all have the financial flexibility for M&A: Moody's
Fierce Pharma
Tue, 06/21/22 - 11:56 pm
Tags:
Pfizer, Merck, Bristol Myers Squibb, patents, patent cliffs, M&A
Merck, Emergent, Affinivax and Ocugen Level Up in Vaccine Development
BioSpace
Tue, 06/21/22 - 12:02 pm
Tags:
Merck, Emergent BioSolutions, Affinivax, Ocugen, vaccines, chikungunya virus, pneumococcal disease, COVID-19

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.